8-K
filed June 16, 2023, 7:59 PM ET
CIK 0001402479
other
confidence high
sentiment negative
materiality 0.70
MedAvail Holdings, Inc.: auditor change — MedAvail shareholders approve reverse split 1:30-1:80; issue warrants for 49.8M shares
MedAvail Holdings, Inc.
- Reverse split approved with 70.4M votes for, 1.35M against; ratio range 1:30 to 1:80, board to set final ratio.
- Series A warrants for up to 49.8M shares at $0.38544/share issued to 4 institutional investors, 5-year term.
- Auditor changed: Baker Tilly resigned May 18; SingerLewak engaged as independent public accounting firm effective June 14.
- Class III directors elected: Faulkner, Stettin, Kramer; each received majority votes at annual meeting.
Key facts
Extracted from this filing and checked against the source text.
Auditor Changes
SEC 8-K Item 4.01/4.02
confidence 0.9
MedAvail Holdings, Inc. engaged SingerLewak LLP as its auditor.
- Action
- engagement
- Auditor
- SingerLewak LLP
Exact text from the filing
On June 14, 2023, MedAvail Holdings, Inc. engaged SingerLewak LLP as our independent registered public accounting firm.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
MedAvail Holdings, Inc. shareholders approved Election of three Class III directors to serve until the 2026 annual meeting at the 2023-06-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
The stockholders elected each of the three persons named below as Class III directors to serve until the 2026 annual meeting of stockholders or until their successors are duly elected and qualified.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
MedAvail Holdings, Inc. shareholders approved Approval of an amendment of our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock at a ratio in the range of not less than 1-for-30 and no greater than 1-for-80 at the 2023-06-14 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
The stockholders approved an amendment of our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock at a ratio in the range of not less than 1-for-30 and no greater than 1-for-80, with such ratio to be determined in the discretion of our board of directors or a duly authorized committee thereof.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
MedAvail Holdings, Inc. shareholders approved Approval of the issuance of 20% or more of the outstanding shares of our common stock at a price less than the Minimum Price as defined by and in accordance with Nasdaq Listing Rule 5635(d) upon the exercise of certain pre-funded warrants and series A warrants at the 2023-06-14 meeting.
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
The stockholders approved the issuance of 20% or more of the outstanding shares of our common stock at a price less than the Minimum Price as defined by and in accordance with Nasdaq Listing Rule 5635(d) upon the exercise of certain pre-funded warrants and series A warrants issued in a private placement of our securities.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.